Evidence map›Paper›PMID 32606719›Full record

ReviewVascular health and risk management2020

Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management.

Jorge Hernández-Cerda, Vicente Bertomeu-González, Pilar Zuazola, Alberto Cordero

Open access · goldAbstract readReview
In one paragraph

Review in Vascular health and risk management, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Hypertension and erectile dysfunction: The role of endovascular therapy in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2021
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jorge Hernández-CerdaCardiology Department, Hospital Universitario de San Juan, Alicante, Spain.
Vicente Bertomeu-GonzálezCardiology Department, Hospital Universitario de San Juan, Alicante, Spain.
Pilar ZuazolaCardiology Department, Hospital Universitario de San Juan, Alicante, Spain.
Alberto CorderoCardiology Department, Hospital Universitario de San Juan, Alicante, Spain.ORCID 0000-0003-0000-7109
Universitat de Miguel Hernández d'Elx · ESHospital Universitari Sant Joan D'Alacant · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erectile dysfunction (ED) is defined as a man's consistent or recurrent inability to attain and/or maintain penile erection enough for successful vaginal intercourse. ED affects a large part of the population, increasing its incidence with age and comorbidities. It is estimated by the year 2025, 322 million men will suffer from ED. Incidence of ED has been related not only to chronic diseases such as diabetes mellitus, metabolic syndrome, hyperlipidemia, psychiatric diseases or urinary tract diseases, but also to hypertension and especially to antihypertensive treatments. This review summarizes current knowledge about the management of ED in hypertensive men and its role as cardiovascular disease predictor.

Indexed as

Antihypertensive AgentsBlood PressureClinical Decision-MakingErectile DysfunctionHumansHypertensionMalePenile ErectionPhosphodiesterase 5 InhibitorsRisk FactorsTreatment OutcomeAntihypertensive AgentsPhosphodiesterase 5 Inhibitorsantihypertensive agentscardiovascular diseaseserectile dysfunctionhypertension

Identifiers

PMID32606719
PMCPMC7297457
OpenAlexW3035163389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.